tiprankstipranks
eFFECTOR Therapeutics (EFTR)
NASDAQ:EFTR

eFFECTOR Therapeutics (EFTR) Financial Statements

207 Followers

eFFECTOR Therapeutics Financial Overview

eFFECTOR Therapeutics's market cap is currently ―. The company's EPS TTM is $-17.112; its P/E ratio is -0.79; eFFECTOR Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-2.21. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--$ 675.00K$ 0.00$ 0.00
Gross Profit--$ 675.00K--
EBIT$ -7.64M$ -9.55M$ -8.77M$ -8.99M$ -6.41M
EBITDA-$ -9.58M$ -61.76M$ -8.97M$ -6.41M
Net Income Common Stockholders$ -8.36M$ -10.01M$ -9.26M$ -9.56M$ -6.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.02M$ 19.01M$ 26.31M$ 32.96M$ 41.04M
Total Assets$ 26.89M$ 21.71M$ 29.08M$ 36.65M$ 43.47M
Total Debt$ 94.00K$ 109.00K$ 120.00K$ 20.22M$ 20.15M
Net Debt$ -24.93M$ -18.90M$ -26.19M$ -12.74M$ -20.89M
Total Liabilities$ 24.31M$ 26.74M$ 25.18M$ 25.09M$ 23.85M
Stockholders Equity$ 2.58M$ -4.81M$ 3.94M$ 11.56M$ 19.62M
Cash Flow-
Free Cash Flow-$ -7.64M$ -6.78M$ -8.23M$ -4.51M
Operating Cash Flow$ -8.59M$ -7.64M$ -6.78M$ -8.18M$ -4.44M
Investing Cash Flow$ -1.57M$ 9.03M$ 3.62M$ 3.62M$ 3.17M
Financing Cash Flow$ 14.57M$ 212.00K$ -37.00K$ 111.00K$ -42.00K
Currency in USD

eFFECTOR Therapeutics Earnings and Revenue History

eFFECTOR Therapeutics Debt to Assets

eFFECTOR Therapeutics Cash Flow

eFFECTOR Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis